# Immitra Bio

**Source:** https://www.startuphub.ai/startups/immitra-bio
**Profile type:** Startup

> Scalable, one-time curative in-vivo gene editing therapies.

## About

Immitra Bio is developing a scalable, in-vivo gene editing platform designed to offer a single, off-the-shelf injection to cure rare genetic diseases. Their mission is to provide accessible, curative genetic medicine for the 400 million people worldwide affected by these conditions, addressing the limitations of current ex-vivo therapies.

## Key facts

- **Slug:** immitra-bio
- **Website:** https://www.immitrabio.com/
- **Location:** Zürich, Switzerland
- **Founded:** 2024-01-01 00:00:00
- **Operating status:** Active
- **Total funding:** $3M
- **Sectors / tags:** Biotechnology, Gene Therapy, Genetics, Healthcare, Pharmaceuticals, Biotech, MedTech, Genomics, Drug Discovery, Gene Editing, Therapeutics, Precision Medicine, In-vivo Gene Editing
- **Social:**
  - LinkedIn: https://www.linkedin.com/in/jan-nelis

## Frequently asked

### What does Immitra Bio do?

Immitra Bio is developing a scalable, in-vivo gene editing platform designed to offer a single, off-the-shelf injection to cure rare genetic diseases. Their mission is to provide accessible, curative genetic medicine for the 400 million people worldwide affected by these conditions, addressing the limitations of current ex-vivo therapies. (formerly [].)

### How much funding has Immitra Bio raised?

Immitra Bio has raised a total of $3M in funding. The most recent round on record is Pre-Seed.

### Where is Immitra Bio headquartered?

Immitra Bio is headquartered in Zürich, Switzerland.

### When was Immitra Bio founded?

Immitra Bio was founded in 2024.

### What industry does Immitra Bio operate in?

Immitra Bio operates in Biotechnology, Gene Therapy, Genetics, Healthcare, Pharmaceuticals, Biotech.

### What is Immitra Bio's revenue?

StartupHub estimates Immitra Bio's annual revenue at $315K (range $85K to $946K, 36% confidence), based on comparable companies in the sector.

### What is Immitra Bio's valuation?

StartupHub estimates Immitra Bio's effective valuation at $9.7M (range $6.5M to $15.5M, 25% confidence), based on comparable companies in the sector.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Immitra Bio",
          "item": "https://www.startuphub.ai/startups/immitra-bio"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/immitra-bio#webpage",
      "url": "https://www.startuphub.ai/startups/immitra-bio",
      "name": "Immitra Bio - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Immitra Bio (formerly []). Immitra Bio is a startup founded in 2024, operating in Biotechnology and Gene Therapy. Scalable, one-time curative in-vivo gene editing therapies. Headquartered in Zürich, Switzerland.",
      "dateModified": "2026-07-22T12:05:19.243+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/immitra-bio#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/immitra-bio#organization",
      "name": "Immitra Bio",
      "url": "https://www.immitrabio.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/0c56c097-8b1b-4418-9f9a-c58ec4f0e0f9-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/0c56c097-8b1b-4418-9f9a-c58ec4f0e0f9-square.webp",
      "description": "This is the official profile of Immitra Bio (formerly []). Immitra Bio is a startup founded in 2024, operating in Biotechnology and Gene Therapy. Scalable, one-time curative in-vivo gene editing therapies. Headquartered in Zürich, Switzerland.",
      "sameAs": [
        "https://www.linkedin.com/in/jan-nelis",
        "https://www.startuphub.ai/startups/immitra-bio"
      ],
      "foundingDate": "2024-01-01 00:00:00",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Zürich",
        "addressCountry": "Switzerland"
      },
      "knowsAbout": [
        "Biotechnology",
        "Gene Therapy",
        "Genetics",
        "Healthcare",
        "Pharmaceuticals",
        "Biotech",
        "MedTech",
        "Genomics",
        "Drug Discovery",
        "Gene Editing",
        "Therapeutics",
        "Precision Medicine",
        "In-vivo Gene Editing"
      ]
    }
  ]
}
```